Next Article in Journal
In Vitro Evaluation of Gastrointestinal Stability of Pediococcus pentosaceus Isolated from Fermented Maize and Pearl Millet for Possible Novel Chicken Probiotic Development
Previous Article in Journal
A Quadruplex Reverse Transcription Quantitative Polymerase Chain Reaction for Detecting Canine Coronavirus, Canine Rotavirus, Canine Parvovirus, and Canine Distemper Virus
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil

1
Laboratory of Agro-Alimentary and Health, Faculty of Sciences and Techniques, Hassan First University of Settat, B.P. 539, Settat 26000, Morocco
2
Higher Institute of Nursing Professions and Health Technical (ISPITS), Marrakech 40000, Morocco
3
Laboratory of Physical Chemistry of Processes and Materials, Faculty of Sciences and Techniques, Hassan First University, Settat 26000, Morocco
4
Regional Center of Agronomic Research of Settat, Tertiary Road 1406, At 5 Km, Settat 26400, Morocco
5
Laboratory of Biochemistry, Neurosciences, Natural Ressources and Environment, Faculty of Sciences and Techniques, Hassan First University of Settat, B.P. 539, Settat 26000, Morocco
6
Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 20th Carol I Avenue, 700506 Iasi, Romania
7
Center of Biomedical Research, Romanian Academy, Iasi Branch, Teodor Codrescu 2, 700481 Iasi, Romania
8
Academy of Romanian Scientists, 3 Ilfov, 050044 Bucharest, Romania
9
Clinical Department, Apollonia University, Pacurari Street 11, 700511 Iasi, Romania
10
Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania
*
Authors to whom correspondence should be addressed.
Microbiol. Res. 2024, 15(2), 762-786; https://doi.org/10.3390/microbiolres15020050
Submission received: 12 March 2024 / Revised: 25 April 2024 / Accepted: 8 May 2024 / Published: 13 May 2024

Abstract

:
Antibiotics play a crucial role in preserving and improving public health, saving millions of lives every year. However, their effectiveness is currently under threat due to the ability of bacteria to adapt and develop resistance to these treatments. Therefore, this study was carried out on two soil samples collected in two areas of Arba Aounate, Sidi Bennour province, Morocco, to identify natural antibiotic-producing Actinobacteria capable of combating multi-drug-resistant (MDR) bacteria. A primary screening revealed that of the 50 isolates, 16 exhibited antimicrobial activity against Pseudomonas aeruginosa ATCC 27,853, Staphylococcus aureus ATCC 25,923, Escherichia coli ATCC 25,922, and Candida albicans ATTC 60193. A secondary screening showed that of the 16 isolates, only EIZ1 and EIZ2 isolates displayed outstanding antimicrobial and antifungal activity against 6 MDR bacteria, including Escherichia coli 19L2418, Listeria monocytogenes, Proteus sp. 19K1313, Klebsiella pneumoniae 19K 929, Proteus vulgaris 16C1737, and Klebsiella pneumoniae 20B1572. These two isolates were also characterized culturally, morphologically, physiologically, and biochemically. Afterward, the amplification of 16S rRNA revealed that isolate EIZ2 was 99.06% strongly related to the genus Streptomyces. Furthermore, this extract exhibits strong antioxidant activity against DPPH and ABTS free radicals and elevated ferric-reducing antioxidant power. A significant (p < 0.0001) positive correlation was observed between antioxidant activities and total phenolic and flavonoid contents. A GC–MS analysis of the ethyl acetate extract revealed the presence of 10 compounds, mainly diethyl phthalate (97%) and benzeneacetic acid (94%). This research demonstrates that Streptomyces sp. strain EIZ2 represents a potential source of antimicrobial and antioxidant compounds. These compounds could offer considerable potential as therapeutic agents, paving the way for future developments in medical applications.

1. Introduction

The emergence and widespread dissemination of multi-drug-resistant (MDR) pathogens represent a serious threat to global public health [1,2]. Antibiotic resistance, a consequence of bacterial acquisition of genetic mutations or resistance genes [3,4], makes standard antibiotics ineffective [5]. Recent statistics indicate that antibiotic-resistant infections contribute to over 35,000 deaths annually in the United States alone [6], while globally, they are responsible for approximately 700,000 deaths per year [7], resulting in heightened rates of illness and mortality. Simultaneously, the disruption of cellular equilibrium by the imbalance in reactive oxygen species (ROS) production establishes oxidative stress as a significant mechanism, with considerable implications for human health [8]. Uncontrolled oxidative stress can initiate a cascade of adverse effects, significantly elevating the risk of chronic conditions such as neurological disorders, cardiovascular diseases, cancer, and kidney disorders [8,9,10]. It was reported that ROS play a multifaceted role in bacterial survival, adaptation, and the development of MDR [11]. For instance, ROS can cause direct DNA damage, leading to genetic mutations that facilitate the emergence of MDR [12,13]. On the other hand, certain non-antibiotic drugs, including non-steroidal anti-inflammatory drugs (NSAIDs) and lipid-lowering medications, can increase ROS levels, which in turn promotes the transfer of antibiotic-resistance genes [14].
This pressing challenge underscores the urgent need for innovative antimicrobial strategies to combat evolving resistance mechanisms [2,15]. Therefore, to expand the array of treatments available for antibiotic-resistant infections, numerous studies have focused on investigating microorganisms, particularly Streptomyces, across diverse environments [16,17,18] to develop new bioactive compounds from microbial sources [19,20,21]. Actinobacteria, diverse Gram-positive bacteria, play a crucial role in addressing global multi-drug resistance [22]. Renowned for their ability to produce potent secondary metabolites with antimicrobial, antifungal, and antioxidant properties, these microorganisms are ubiquitous in various environments, including soil, marine habitats, and human microbiota. Belonging to the phylum Actinobacteria, notable genera include Streptomyces, Micromonospora, Nocardia, and Actinomyces [23].
Given the significance of Actinobacteria in addressing global multi-drug resistance, this research contributes to the understanding of Actinobacteria-derived bioactive compounds’ antimicrobial and antioxidant activities and their potential in combating multi-drug resistance. To the best of our knowledge, there is no available information on the biological activities of Streptomyces strains isolated from agricultural soils in Arba Aounate, Sidi Bennour province, Morocco. Specifically, this study aimed to: (1) isolate Actinobacteria strains from Arba Aounate in Sidi Bennour, Morocco, and assess soil physicochemical parameters; (2) conduct a primary screening of Actinobacteria isolates for their antimicrobial activity; (3) perform morphological, biochemical, and physiological characterizations of the isolated Actinobacteria, accompanied by 16S rRNA gene sequencing analyses; (4) evaluate the antimicrobial efficacy of selected isolates exhibiting high activity against Escherichia coli ATCC 25,922, Pseudomonas aeruginosa ATCC 27,853, Staphylococcus aureus ATCC 25,923, Candida albicans ATCC 60,193 and six multi-drug-resistant pathogens, including Escherichia coli 19L2418, Listeria monocytogenes, Proteus sp. 19K1313, Klebsiella pneumoniae 19K 929, Proteus vulgaris 16C1737, and Klebsiella pneumoniae 20B1572; (5) determine the antioxidant activity of the selected isolates and analyze the polyphenol and flavonoid contents in their extracts; (6) assess the toxicity of the selected isolates using UV-visible and hemolytic activity assays; and (7) identify the profile of the main compounds of the most active isolate (determined based on high antimicrobial and antioxidant activities) using gas chromatography–mass spectrometry (GC–MS) analysis. This work aimed to not only identify potent antimicrobial and antioxidant agents from Actinobacteria but also assess their safety and explore their chemical composition, paving the way for potential therapeutic applications in combating multi-drug resistance and oxidative stress-related disorders.

2. Materials and Methods

2.1. Collecting Soil Samples

The soil samples used in this study were collected in April 2022 from two locations in Arba Aounate, Sidi Bennour province, Morocco (GPS: 32°44′24′′ N, 8°11′24′′ W). In order to avoid species similarity between Actinobacteria, soil samples were taken at five different points in a 400 m2 area for each site [19,24]. After removing the top few centimeters of soil, each sample was taken to a depth of 10 cm from the top layer of soil. Approximately 200 g of soil was carefully placed into a sterile bottle using a sterile spatula, with the reference duly noted. The collected soil samples were then transported to the laboratory and conserved at 4 °C until use [19].

2.2. Physico-Chemical Soil Analysis

The pH of each soil sample was determined using a calibrated pH meter (OCRISON, micro-pH 2000). The electrode was immersed in a suspension at a ratio (soil/distilled water) of 2:5 (g/mL). Electrical conductivity (EC) was determined using a conductivity meter (Seven GoT M). Texture characterization was performed using the sedimentation technique. Briefly, 25 g of soil were placed in a glass beaker containing one-third distilled water. The mixture was then stirred and left to stand for 2 days to allow the three soil phases to emerge: clay, silt, and sand. Chemical elements such as Mg, Si, Fe, K, Zn, Mn, Cl, Al, P, Cu, and S were analyzed by energy-dispersive X-ray fluorescence (Epsilon 3XLE from PANalytical, France) [25].

2.3. Pre-Treatment of Soil Samples and Isolation of Actinobacteria Strains

The pre-treatment process is essential for the selective isolation of Actinobacteria, which are known to grow more slowly than other microorganisms. Typically, this process involves drying soil samples at room temperature (around 26 °C) in the laboratory for 7 days, thereby inhibiting or eliminating unwanted Gram-negative bacteria [26]. The isolation was carried out using the serial dilution technique [27]. Briefly, 10 g of each soil sample were ground and mixed with 90 mL of distilled water in an Erlenmeyer flask while noting the reference of each sample. The resulting suspension (10−1) was agitated at maximum speed for 30 min. After settling, the supernatants were collected, and a series of decimal dilutions (10−1 to 10−4) were prepared. Four different culture media (Bennett, GLM, M2, and GA) were employed for Actinobacteria isolation. The detailed compositions of these media are provided in the supplementary data [28,29,30,31], and these media were inoculated with a volume of 100 µL per dilution (10−1, 10−2, 10−3, and 10−4) per Petri dish (4 dishes for each medium) [19]. Plates were incubated at 28 °C and checked daily for one week.

2.4. Preliminary Identification of Actinobacteria Isolates

Colonies displaying typical macroscopic characteristics of Actinobacteria, such as being solid, pigmented or whitish, strongly adherent to the agar surface, and featuring a compact, dry, smooth, or rough texture, were cultured in ISP2 medium. These colonies were then examined under a light microscope at 40× magnification and after Gram staining at 100× magnification. Purified isolates underwent a 7-day incubation at 28 °C, were subsequently stored at 4 °C, and were suspended in glycerol before being preserved for the long term at −20 °C [32].

2.5. Genotypic Identification and Phylogenetic Tree Construction

Genotypic identification involved 16S rDNA sequencing to confirm isolate species. DNA extraction used the Mag Purix Bacterial DNA Extraction Kit, following the manufacturer’s instructions. The DNA extracted from a specific Actinobacteria isolate was quantified using a NanoDrop 8000 spectrophotometer (Thermo Scientific, Waltham, MA, USA) and then stored at −20 °C until use. The concentration of the extracted DNA from this isolate was adjusted to 100 ng/µL for the PCR reaction. The 16S rRNA gene was amplified with the universal primers Fd1 (5′-AGAGTTTGATCATGGCTCAG-3′) and rP2 (5′-ACGGTTACCTTGTTACGACTT-3′) in a Verity DNA thermal cycler [33]. The cycling program included initial denaturation at 95 °C for 2 min, followed by 35 cycles of denaturation at 95 °C for 30 s, annealing at 52 °C for 30 s, extension at 72 °C for 30 s, and a final extension at 72 °C for 3 min. Sequencing of successful PCR products was conducted on a 3130x1 genetic analyzer. The National Center for Scientific and Technical Research (CNRST) in Rabat, Morocco, conducted extraction, amplification, and sequencing. Nucleotide sequences were analyzed using the BLAST program on the NCBI website. Assembled sequences used DNA Baser Assembler software, and MEGA X software aligned sequences with the refseq_rna database archived in the Genomic Data Bank, which is accessible on the Internet at the National Center for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov), accessed on 31 October 2023 [34]. The phylogenetic tree employed the maximum likelihood method [34].

2.6. Evaluation of Antimicrobial Activity

2.6.1. Test Bacteria Used

The study employed three bacterial strains (Escherichia coli ATCC 25,922, Pseudomonas aeruginosa ATCC 27,853, and Staphylococcus aureus ATCC 25,923) and Candida albicans ATCC 60,193, a pathogenic fungus, sourced from the Pasteur Institute in Casablanca, Morocco. In addition to these strains, 6 clinically pathogenic multi-drug-resistant (MDR) strains, namely Escherichia coli 19L2418, Listeria monocytogenes, Proteus sp. 19K1313, Klebsiella pneumoniae 19K 929, Proteus vulgaris 16C1737, and Klebsiella pneumoniae 20B1572 were also included in the study. The antibiotic resistance profile of the clinically tested MDR strains was confirmed using 16 different antibiotics (Supplementary Table S1).

2.6.2. Primary Screening of Actinobacteria Isolates for Antimicrobial Activity

Antimicrobial activity was evaluated using the double-layer technique described by Badji et al. [35] against Pseudomonas aeruginosa ATCC 27,853, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25,922, and a pathogenic fungus (Candida albicans ATCC 60,193). Actinobacteria isolates were seeded in 10 mm diameter keys, either at the edge [36] or in the center [35] of a 90 mm diameter Petri dish containing ISP2 medium. After a 10-day incubation in an oven at 28 °C, the cultures were covered with 5 mL of Muller–Hinton medium, weakly agarized (7 g/L agar) and previously seeded with a test bacterium. Antimicrobial activity was assessed by measuring the zones of inhibition in mm.

2.6.3. Fermentation and Extraction of Secondary Metabolites

Erlenmeyer flasks at a size of 250 mL were used for this experiment. In each flask, 100 mL of agar-free ISP2 liquid medium was inoculated with active Actinobacteria isolates (EIZ1 and EIZ2). The Erlenmeyer flasks were then incubated for 3 days under constant agitation at 120 rpm on a shaker at room temperature [27].
Liquid–liquid extraction involves transferring solutes between immiscible solvents. Despite facilitating substance transfer, vigorous mixing during this process can form emulsions, complicating phase separation [37]. In this study, the objective was to recover secondary metabolites, specifically fermentation products. After fermenting, the mycelial mass is removed via centrifugation at 8000× g for 20 min [38]. Supernatant from each medium is mixed with dichloromethane in a separating funnel. The resulting aqueous phase is then combined with an equal volume of ethyl acetate. Organic extracts are obtained and evaporated at 45 °C using a rotary evaporator (Buchi B-491 Heating Bath). Dry residues were subsequently solubilized in DMSO [39].

2.6.4. Evaluation of the Antimicrobial Activity of Organic Extracts

To assess antimicrobial activity in liquid medium, the disc technique was used [35] against 6 clinical MDR strains (Proteus sp. 19K1313, Proteus vulgaris 16C1737, Klebsiella pneumoniae 19K 929, Listeria monocytogenes, Escherichia coli 19L2418, and Klebsiella pneumoniae 20B1572), and Candida albicans ATCC 60,193. For the assay, sterile 6 mm diameter filter paper discs were impregnated with 20 µL of each extract. As a negative control, a disc loaded with an equivalent volume of dimethyl sulfoxide (DMSO) to that of the extract was used. Nalidixic acid and cycloheximide served as positive controls for antibacterial and antifungal activities, respectively. The impregnated discs were left to dry for a few min using a Bunsen burner, then placed with sterile forceps on the surface of Muller–Hinton medium previously inoculated with test bacteria using the swabbing technique. The plates were then placed at 4 °C for 2 h to allow for diffusion of the molecules, then incubated at 37 °C for 24 h. Afterward, the diameter of inhibition zones was measured in mm after 24 h of incubation at 37 °C for bacteria and 48 h at 28 °C for fungi.

2.6.5. Cultural, Physiological, and Biochemical Characteristics of Actinobacteria Isolates

The cultural characteristics, such as extent of growth, pigmentation of the surface and reverse (the back of the colony), colony diameter, colony appearance, and presence of diffusible pigments in the agar of two isolates EIZ1 and EIZ2, were determined on the following culture media (ISP1, ISP2, ISP7, GYEA, and Bennett) by inoculating each Actinobacteria isolate on all 5 media using the tight streak method. The plates were then incubated at 28 °C for 10 days [35]. Actinobacteria isolates were inoculated in ISP2 solid culture medium buffered to different pH values (4.02; 5.02; 6.45; 7.28; 8.02; 9.06; and 10.02) with NaOH (sodium hydroxide) or HCL (hydrochloric acid) solutions [40]. The growth of two isolates was assessed visually after 7 days incubation at 28 °C.
The tolerance of Actinobacteria to NaCl was tested on a yeast extract agar medium (Supplementary Materials) supplemented with a graduated series of NaCl concentrations (1, 2, 3, 4, 5, 6, 7, 8, 9, and 10%). Then, we inoculated our Actinobacteria isolates into YEA-NaCl medium using the tight streak method at each NaCl concentration. After inoculation, plates were incubated at 30 °C for 4 days [41]. The medium used to test carbohydrate uptake by purified Actinobacteria isolates was ISP9 (Supplementary Materials), which is rich in mineral components. We added simple sugars and other complexes as carbon sources (starch, mannitol, cellobiose, sucrose, xylose, mannose, fructose, and glucose (positive control)). After inoculation of our Actinobacteria isolates by the tight streak method, plates were incubated at 28 °C for one week.

2.7. Determination of Total Phenolic and Flavonoid Contents

The determination of total polyphenols contained in the ethyl acetate extract of Actinobacteria isolate EIZ2 was conducted using the Folin–Ciocalteu method described by Kumazawa et al. [42], whereas the total flavonoid content in the same extract was quantified according to Bahorun et al. [43].

2.8. Evaluation of the In Vitro Antioxidant Activities

The free radical scavenging activity of the ethyl acetate (EA) extract from Streptomyces sp. EIZ2 was assessed using the DPPH assay, following the protocol outlined by Blois [44]. Absorbance measurements were performed at 517 nm with an ELISA microplate reader (2100-C, Optic Ivymen Systems, Barcelona, Spain). As a positive control, ascorbic acid was used. Additionally, the free radical scavenging activity (ABTS) was determined based on the method developed by Re et al. [45], with Trolox serving as the positive control. Concerning the ferric-reducing antioxidant power (FRAP), it was evaluated according to the procedure described by Oyaizu [46]. Measurements were conducted in triplicate, and ascorbic acid was employed as a positive antioxidant control.

2.9. UV-Visible Analysis

The absorption spectra of Streptomyces sp. EZ2 ethyl acetate extract were measured at wavelengths ranging from 190 to 850 nm using a HACH Lange DR6000 scanning UV-visible spectrophotometer [47].

2.10. Evaluation of Hemolytic Activity

The hemolytic activity of the ethyl acetate of EIZ2 isolate was evaluated using a hemolysis assay with human red blood cells (RBCs), following the methods reported by Rajendran et al. [48] and Zhu et al. [49] with some modifications. Human erythrocytes (RBCs) were collected from healthy individuals in tubes with purple caps containing EDTA as an anticoagulant. An amount of 2 mL of whole blood was combined with 4 mL of phosphate-buffered saline (PBS) and subjected to centrifugation at 9000× g for 5 min at 24 °C. The resulting supernatant was discarded, and the pellet was washed twice with 10 mL of PBS, then ultimately diluted to 20 mL using PBS. An amount of 400 µL of the diluted RBC suspension was mixed with 1.6 mL of each extract prepared in PBS, spanning concentrations of 0.125, 1.25, and 3.12 mg/mL for the test group. Additionally, PBS served as the negative control, while sodium dodecyl sulfate (SDS) was the positive control. The experimental setup was duplicated. Tubes were incubated at 37 °C for 1 h and subsequently centrifuged for 5 min at 5000× g.

2.11. GC–MS Analysis of EIZ2 Strain Crude Ethyl Acetate Extract

Analysis of the profile of compounds present in the crude ethyl acetate extract of strain EIZ2 was carried out by gas chromatography coupled with mass spectrometry (GC–MS) on an Agilent 7890A Series instrument. The system was equipped with a multimode injector and an HP-5MS column with the dimensions 30 m × 0.250 mm × 0.25 μm at the Moroccan Foundation for Advanced Science, Innovation and Research (MAScIR) Institute. Briefly, a volume of the extract solubilized in chloroform was injected into the column (split mode 1:4) with helium as a carrier gas at a flow rate of 1.7 mL/min. The ion source and quadrupoles were maintained at temperatures of 230 and 150 °C, respectively. The oven temperature program started at 60 °C and ended at 360 °C. Compound identification was carried out by comparing the mass spectra obtained with reference data from the NIST MS 2017 library.

2.12. Statistical Analysis

The experiments were conducted in triplicate, and the results were presented as the mean value along with the standard deviation (SD). To assess differences between groups in phenolic compound, flavonoid compound, and antioxidant activity assays, GraphPad Prism 8.4.3 software was used. Specifically, we utilized a standard two-way ANOVA test followed by Tukey’s multiple comparisons test. Statistical significance was set at p < 0.05. Pearson correlation analysis was conducted using GraphPad Prism 8.4.3 software to assess the relationship between total phenolic and flavonoid compounds and antioxidant activity.

3. Results

3.1. Physico-Chemical Analysis of Soil Samples

The pH, electrical conductivity, texture, and minerals measured for the two soil samples are shown in Table 1. Analysis of the soil at Site A indicated that it possesses alkaline characteristics with a pH level of 8.08 and is not saline, as evidenced by its low electrical conductivity (EC = 0.004 ds/m). According to the textural diagram, it falls into the clay-loam category and has a relatively low sand content of 28%. Our observations also unveiled the presence of various exchangeable cations, including K, Mg, Al, Ca, Fe, Zn, Cu, and Si. Notably, mineral elements like Si, Fe, Al, K, and Ca were found in higher concentrations (Table 1). In contrast, the soil at Site B leans slightly towards alkalinity, is predominantly sandy (75%), and displays not-salty characteristics (EC = 0.003 ds/m). This soil type has a lower proportion of clay and silt and generally lower concentrations of mineral elements, except for Si, which is specifically abundant at 21.22%. Comparing the pH values of the soils at both sites, we observed variations among different soil textures. The lowest pH value (7.79) was recorded in the Argilo-loamy texture at Site A, while the highest pH value (8.08) was documented in the sandy texture at the same location.

3.2. Isolation of Actinobacteria

For the isolation of Actinobacteria, the following media were selected: Bennett, GLM, M2, and GA were chosen as selective culture media suitable for Actinobacteria to grow. Numerous colonies, distinguished by their macroscopic aspect, appeared after one week of incubation. These were isolated and then subcultured in ISP2 medium. Colony counts for both soil samples in all media were shown in Table 2. In our study, we isolated a total of 50 distinct phenotypically presumed Actinobacteria isolates from soil samples obtained from the two sampling locations. These isolates were distributed as follows: 58% from Site A and 42% from Site B (Table 2). M2 medium produced the highest number of isolates (n = 27), followed by Bennett (n = 16), GLM (n = 7), and GA (n = 0) (Table 2). According to the results, only the M2 and Bennett media had significant numbers of Actinobacteria colonies, then the GLM medium with low numbers in the two soil samples; however, no colonies appeared in the GA medium.

3.3. Primary Screening of Actinobacteria Isolates

Among the 50 Actinobacteria isolates, only 16 (32%) showed important antimicrobial activity against at least one test microorganism, including Gram-positive bacteria such as Staphylococcus aureus ATCC 25,923, Gram-negative bacteria such as Escherichia coli ATCC 25 922, and Pseudomonas aeruginosa ATCC 27,853 and Candida albicans ATCC 60,193 (Table 3, Figure 1).

3.4. Secondary Screening of Actinobacteria Isolates

The 16 bioactive isolates that showed antimicrobial activity against at least one test microorganism in the primary screening were subjected to a secondary screening against certain multi-drug-resistant (MDR) pathogenic bacteria (Table 4, Figure 2), as well as against Candida albicans ATCC 60,193. The greatest zones of inhibition were observed with ethyl acetate and dichloromethane extracts. It should be noted that EIZ1, tested in liquid medium, showed no observable antimicrobial or antifungal activity. In contrast, EIZ2 showed significant activity against all six multi-drug-resistant clinical bacterial strains tested, indicating its broad-spectrum antimicrobial (p < 0.05) potential. Of the extracts tested, the ethyl acetate of EIZ2 consistently showed the largest and most pronounced areas of antimicrobial activity.

3.5. Micro-Morphological, Biochemical, and Physiological Characteristics of Isolates

Among the 16 bioactive isolates tested, only 2 showed notable antimicrobial activity (EIZ1 and EIZ2), which led to their selection for taxonomic, physiological, and biochemical investigations (Figure 3, Table 5). The macroscopic characteristics of the two isolates are as follows: EIZ1 exhibits a round, wrinkled surface with a powdery texture, appearing whitish towards the ends and firmly adhered to the agar surface. In contrast, EIZ2 displays a smooth, powdery surface, also firmly attached to the agar. Both Actinobacteria isolates grow over a wide pH range. EIZ1 was able to grow in pH values ranging from 5.02 to 10.02, and EIZ2 in a wider range from 4.02 to 10.02. Additionally, both isolates tolerated NaCl concentrations ranging from 1% to 7%, while EIZ2 was able to grow in concentrations of up to 10%. Furthermore, when assessing their growth preferences on different culture media, both isolates exhibited strong growth in ISP1, ISP2, ISP7, GYEA, and Bennett media. In particular, macroscopic observation of the two Actinobacteria isolates showed the production of melanoid pigments by isolate EIZ2 after one week of incubation at 28 °C: a brown exogenous pigmentation diffused in the agar around the colonies. No pigmentation was produced by isolate EIZ1. Regarding temperature tolerance, both isolates showed high temperature tolerance, growing efficiently in the range between 4 °C and 37 °C. Notably, EIZ2 stood out by even tolerating a high temperature of 45 °C. Under microscopic examination, both isolates, with and without Gram staining, were presented as filamentous and Gram-positive.

3.6. Genotypic Characterization of EIZ2 Isolate and Construction of Phylogenetic Tree

The partial sequencing of the 16S rRNA gene revealed a remarkable 99.06% similarity to Streptomyces bacillaris, as reported in the NCBI GenBank database (Supplementary Table S2). The resulting sequence was aligned with the sequences of 19 closely related Streptomyces sp. obtained from the NCBI GenBank database. These sequences were then assembled in MEGA7 software for phylogenetic analysis using the maximum likelihood method, and evolutionary distances were calculated using Kimura’s two-parameter method. The resulting phylogenetic tree (Figure 4) confirmed the similarity of isolate EIZ2 to Streptomyces bacillaris, with a confidence level represented by the bootstrap value of the similarity matrix reaching 89. The GenBank accession number for the partial 16S rRNA gene sequence of strain EIZ2 is OR731196.

3.7. Total Phenolic Content of Crude Extracts

The results concerning the total polyphenol and flavonoid contents of the ethyl acetate extract of EIZ2 were summarized in Table 6. The data show an increase in both phenolic and flavonoid contents with increasing extract concentration, ranging from 0.261 ± 0.003 to 0.470 ± 0.013 mg GAE/mg extract for phenolics and from 0.006 ± 0.005 to 0.114 ± 0.007 mg QE/mg extract for flavonoid contents. Notably, the concentration of flavonoids in the extract is lower compared with phenolics.

3.8. In Vitro Antioxidant Activities

The results presented in the Table 7 indicate significant DPPH radical scavenging activity (p < 0.0001), with inhibition percentages ranging from 2.91 ± 0.92 to 37.78 ± 1.93% at concentrations ranging from 0.2 to 1 mg/mL. Furthermore, the extract also showed significant ABTS radical scavenging activity (p < 0.0001), with inhibition percentages ranging from 1.32 ± 1.96 to 30.58 ± 1.78% at concentrations ranging from 0.2 to 1 mg/mL. Regarding the antioxidant reducing power of iron (FRAP), the extract demonstrated significant iron-reducing activity (p < 0.0001), measured from 0.43 ± 0.01 to 0.89 ± 0.02 mg AAE/mg extract at concentrations of 0.2 to 1 mg/mL.

3.9. Correlation between Antioxidant Activities and Total Phenolic and Flavonoid Contents

The Pearson correlation coefficients between the variables are presented in Figure 5A–F. The results showed a highly significant positive correlation between antioxidant activity assessed by DPPH, FRAP, and ABTS assays and the levels of polyphenols and flavonoids present in ethyl acetate extract of Streptomyces sp. isolate EIZ2.

3.10. Analysis of Ethyl Acetate Extract of EIZ2 Isolate Using UV-Visible Spectroscopy

The absorption spectrum of ethyl acetate extract of EIZ2 isolate does not exhibit the three absorption peaks characteristic of polyene molecules. Instead, only one absorption peak was observed at 295 nm (Figure 6).

3.11. Evaluation of the Toxicity of EIZ2 Isolate Ethyl Acetate Extract by Hemolysis Test

The findings of Figure 7 revealed that ethyl acetate extract of EIZ2 isolate induced no damage to red blood cells at the tested doses (0.125, 1.25, and 3.12 mg/mL).

3.12. Identification of Bioactive Compounds Using GC–MS

The result of the GC–MS analysis of the ethyl acetate extract derived from strain EIZ2 revealed 10 bioactive compounds, eluting within the time range of 1533 to 21,963 min (Figure 8). Among these identified compounds, eight have been acknowledged for their various biological activities, including antimicrobial, antioxidant, antifungal, anticancer, and others (Table 8). The primary identified compounds include 2,3-diazabicyclo [2.2.1] hept-2-ene,1,4-dimethyl-; hydroxylamine, O-pentyl-; 1,2-ethanediol, monoacetate; ethanol, 2,2’-oxybis-; butanoic acid, 3-hydroxy-3-methyl-; benzeneacetic acid; and diethyl phthalate (Table 8, Supplementary Figure S1).

4. Discussion

The pH range favorable to the growth of Actinobacteria is typically between 6 and 9; this pH range supports the proliferation of Actinobacteria in the soil samples [2]. Certainly, Actinobacteria exhibit heightened sensitivity to acidic conditions [60]. As a result, the average pH of our samples was 7.94, indicating that the pH of the two soils tested was slightly alkaline and did not hinder the growth of Actinobacteria. Soil conductivity plays a crucial role in influencing the growth of Actinobacteria, both directly and indirectly. This conductivity is closely linked to soil moisture levels and water availability. Similar to other microorganisms, Actinobacteria rely on water for their metabolic activities and overall growth. Therefore, lower soil conductivity values are generally preferred as they indicate conditions that are conducive to the water requirements essential for the optimal functioning and growth of Actinobacteria [61]. Elevated soil conductivity may signify the presence of salts or minerals, creating osmotic stress and potentially limiting water availability essential for microorganisms, including Actinobacteria, thereby impeding their growth [61]. Additionally, soil conductivity can impact the availability of crucial nutrients for Actinobacteria [62]. Higher conductivity levels are often associated with increased concentrations of specific ions such as sodium, potassium, and calcium. These ions can disrupt the equilibrium and accessibility of vital nutrients like nitrogen, phosphorus, and micronutrients, crucial for the growth of Actinobacteria [62]. Consequently, imbalances induced by high soil conductivity can compromise the growth capabilities of Actinobacteria [62].
In this study, the higher abundance of Actinobacteria colonies in M2 medium can be explained by the presence of macromolecules (starch and casein) in this medium (M2), which are catabolized by the majority of Actinobacteria, making the medium (M2) favorable to their growth [17]. In addition, this medium contains trace elements essential for bacterial growth [17]. Consequently, the specific factor contributing to the limited growth support of Actinobacteria by GA medium depends on its composition of L-asparagine, which may not provide an adequate nitrogen source for Actinobacteria isolated from the studies region. For subculture, ISP2 medium was chosen because of its balanced combination of nutrients adapted to the needs of Actinobacteria, including those of the Streptomyces genus, which are reputed producers of antibiotics.
In the current study, the macroscopic characteristics of the two isolates align with the characteristics commonly associated with identified Actinobacteria [26]. While Actinobacteria can exhibit tolerance to a wide pH range, their growth rate, metabolic activity, and specific requirements may vary under different pH conditions. Optimal growth for various Actinobacteria species typically occurs within a narrower pH range, usually in neutral or slightly alkaline conditions (pH 6–8) [63]. However, it is worth noting that some Actinobacteria are known to exhibit broader optimum pH values, depending on their ecological niche and adaptation. The optimal salt concentration for the growth of Actinobacteria can vary from nearly zero (0% NaCl) to approximately 5% NaCl, depending on the specific strain and environmental niche of the microorganism [64]. For instance, EIZ2 has the ability to tolerate NaCl concentrations of up to 10%, which can be explained by the unique characteristics of this species. Some Actinobacteria have developed mechanisms to cope with osmotic stress caused by salt, allowing them to maintain their growth and survival. However, it is important to note that the growth of Actinobacteria, like that of other microorganisms, can be inhibited by high salt concentrations (10%) [61,65]. Excessive amounts of NaCl can create osmotic stress, interfere with cellular processes, and disrupt the water balance inside the cells [61]. This can result in reduced growth or even cell death, as observed in the case of the EIZ1 isolate.
The findings of the current study revealed that EIZ1 and EIZ2 exhibit the capability to assimilate a wide range of carbohydrates. In this context, it was reported that Actinobacteria regulate sugar assimilation at the transcriptional level, with gene expression influenced by the presence or absence of specific carbohydrates [66,67]. Various regulatory mechanisms control genes encoding carbohydrate-degrading enzymes, transporters, and other metabolic enzymes [67]. Additionally, Actinobacteria employ diverse carbohydrate transport systems to absorb hydrolyzed molecules into their cells [67,68]. These transport systems can be specific to certain sugars or exhibit a broad substrate specificity, allowing the bacteria to use a wide range of carbohydrate derivatives present in their environment [69]. Additionally, Actinobacteria have the capacity to use alternative carbohydrates, such as pentoses (xylose), disaccharides (sucrose), and other sugar derivatives. Specific transporters and enzymes are involved in the absorption and metabolism of these alternative carbohydrate sources [69].
For most Actinobacteria, the optimal growth temperature falls within the mesophilic range, typically between 20 °C and 40 °C [70]. Nevertheless, exceptions exist, with some Actinobacteria thriving optimally at lower temperatures (psychrophilic) or higher temperatures (thermophilic) [71]. The growth rate of Actinobacteria is generally temperature-sensitive. The growth rate of Actinobacteria is sensitive to temperature variations [2]. Unlike some bacterial groups, Actinobacteria generally demonstrate a slower growth pace, with their growth rates diminishing both at lower and higher temperatures outside their optimal range [19,72]. This temperature sensitivity is characteristic, leading to a modulation in growth rates depending on the temperature conditions. Barka et al. [2] have highlighted these temperature-dependent characteristics of Actinobacteria in their research. Actinobacteria produce melanoid pigments through complex enzymatic pathways, starting with the conversion of amino acids or carbohydrates into intermediate compounds, which are further transformed to yield melanin or melanoid pigments [73]. Furthermore, in many cases, tyrosine serves as a precursor for the production of melanoid pigments [74]. Actinobacteria possess enzymes like tyrosinases, which convert tyrosine into reactive intermediates. These intermediates subsequently undergo polymerization and oxidation processes to form melanin or melanoid pigments [75]. Environmental conditions and culture media composition significantly influence the expression of genes related to pigment biosynthesis in Actinobacteria, thereby affecting pigment production levels [75,76]. Melanoid pigments produced by Streptomyces often serve as protective agents against UV irradiation and adaptive functions [76,77]. They can act as antioxidants, effectively trapping harmful ROS and thus providing protection to the bacteria against oxidative damage [75].
Out of the 16 isolates tested against multi-drug-resistant bacteria, only isolate EIZ2 exhibited important antimicrobial activity. The lack of activity in the other isolates can be attributed to the fact that antimicrobial compounds produced by microorganisms on solid substrates may have limited mobility in liquid media. In solid media, these compounds can diffuse and disperse, making contact with bacteria over a larger surface area [78]. Conversely, in liquid media, the diffusion of these compounds may be restricted, diminishing their range and inhibitory effect. Moreover, the antimicrobial activity of certain compounds may require a longer incubation time to manifest itself in liquid media than in solid media [79]. In the case of EIZ2, ethyl acetate proved to be the most effective extraction solvent. Ethyl acetate is a moderately polar solvent capable of attracting both polar and apolar molecules, making it more likely to extract the desired bioactive molecules [80].
Polyphenols have been associated with various bioactive properties, including antioxidant, anti-inflammatory, anticancer, and antimicrobial activities [19,81,82,83]. Statistical analysis of this study supports this hypothesis, as an excellent positive correlation was found between antioxidant activity and total phenol and flavonoid content. Similarly, Tan et al. [84] reported that the in vitro antioxidant capacity of the MUM212 extract of the Streptomyces sp. strain is mainly due to the presence of phenolic compounds. Furthermore, Yogeswari et al. [85] reported that phenolic compounds have strong antioxidant activity, possessing the ability to donate hydrogen-reducing free radicals.
Our study confirms that phenolic compounds are responsible for the antioxidant activity observed against DPPH, ABTS, and FRAP. This suggests that the EIZ2 isolate tested is capable of producing one or more antioxidants, which could have significant implications for the prevention against oxidative stress. This is a biological process implicated in premature aging and the development of numerous chronic issues, including cardiovascular disease, cancer, and neurodegenerative disorders [86,87,88]. The capacity of the EIZ2 isolate to produce antioxidants may help attenuate the effects of ROS by neutralizing free radicals and reducing cellular damage caused by oxidation. Furthermore, this opens up the possibility of further exploring the antioxidant compounds produced by this isolate, both in terms of basic research and practical applications. For example, these antioxidants could be used in foods or dietary supplements to promote health and prevent disease. In addition, a better understanding of the mechanisms by which these isolates produce antioxidants could lead to advances in biotechnology and the production of natural antioxidants.
The absence of 3 absorption peaks characteristic of polyene molecules in the absorption spectrum of ethyl acetate extract of EIZ2 isolate indicates that this extract likely contains no polyene molecules. The structural similarity between polyene antifungal molecules and cholesterol, in particular ergosterol, the sterol predominant in fungal cells, is responsible for their toxicity [89]. This toxicity has been proven by previous studies [19,89]. Understanding this mechanism is essential for selecting effective, non-toxic antifungal compounds for therapeutic applications. Interestingly, the ethyl acetate extract of EIZ2 isolate did not exhibit hemolysis of red blood cells at the tested concentrations. This result emphasizes the potential therapeutic or biomedical importance of this extract in the prevention of cell damage.
The GC–MS analysis was performed to identify the compounds that could explain the bioactivities of the ethyl acetate extract of the EIZ2 strain. Among the compounds detected were phenolic compounds comprising an aromatic ring bearing one or more hydroxyl groups. These molecules are also recognized for their antioxidant properties [81]. The phenolic compounds detected in strain EIZ2 were benzene acetic acid and diethyl phthalate. They have been previously detected in Streptomyces sp. E23-4 [19]. Moreover, these phenolic compounds were associated with the antimicrobial and antioxidant activities exhibited by this Streptomyces sp. E23-4 strain [19].
The extract from strain EIZ2 revealed the presence of heterocyclic compounds, including 2,3-diazabicyclo [2.2.1] hept-2-ene,1,4-dimethyl. These compounds have been associated with antimicrobial, antioxidant, anticancer, anti-inflammatory, antiallergic, anticonvulsant, herbicidal, and antiseptic activities [50]. In addition, hydroxylamine, O-pentyl- has also been identified in the ethyl acetate extract of strain EIZ2, which showed antimicrobial activity [51]. Moreover, phenolic glycosides like butanoic acid, 3-hydroxy-3-methyl- have been associated with various biological activities, including antioxidant, antimicrobial [55], and anti-herbivore activity [90]. Furthermore, the presence of the ethanol, 2,2’-oxybis- identified in our extract has been previously documented for its diverse biological properties, including antioxidant and antimicrobial activities [54]. Finally, the presence of acetic acid and 1,2-Ethanediol, monoacetate in the extract has been previously documented for their reported antimicrobial and antioxidant properties [52,53]. The wide range of biological activities exhibited by the ethyl acetate extract from strain EIZ2 may potentially be attributed to the collective presence of the identified compounds. Additionally, the elevated antimicrobial and antioxidant activities observed in the EIZ2 strain might be attributed to the synergistic impact of the secondary metabolites existing in the ethyl acetate extract from EIZ2. The outcomes from the GC–MS analysis enable us to deduce that a significant portion of the chemical compounds identified in the ethyl acetate extract of strain EIZ2 are acknowledged for their antimicrobial and antioxidant abilities. Consequently, these identified compounds may be implicated as contributors to the observed antimicrobial and antioxidant activities exhibited by the ethyl acetate extract of strain EIZ2 in the experimental setting. Therefore, further investigations involving the isolation and characterization of individual bioactive compounds, as well as the assessment of their bioactivities using purified forms, are warranted to provide a clearer understanding of their roles in mediating the observed biological effects.

5. Conclusions

In conclusion, the isolation of the EIZ2 strain from garden soil has revealed its remarkable antimicrobial properties against multi-drug-resistant (MDR) bacterial strains and its strong antioxidant activities. Our investigation into Streptomyces sp. EIZ2, derived from previously unexplored garden soil, suggests its potential for large-scale production of antimicrobial and antioxidant agents. The various bioactive compounds identified through gas chromatography–mass spectrometry (GC–MS) in the ethyl acetate extract of strain EIZ2 exhibit a broad range of biological activities. These substances can be considered as potential agents for treating multi-drug-resistant (MDR) bacterial infections and managing conditions associated with oxidative stress, including cancer, cardiovascular diseases, renal disorders, and other pathologies. These findings hold significant implications for the development of therapeutic drugs aimed at addressing multidrug-resistant bacterial infections and diseases associated with oxidative stress. It is crucial to highlight that our conclusions are solely derived from the results of our experiments. Therefore, additional research is necessary to thoroughly characterize and ascertain the chemical structures of the compounds present in the EIZ2 extract, utilizing diverse analytical techniques such as Fourier-transform infrared spectroscopy (FTIR), high-performance liquid chromatography (HPLC), high-resolution mass spectrometry (HRMS), and nuclear magnetic resonance (NMR). Furthermore, further explorations into the intracellular molecular mechanisms of action of the compounds within the EIZ2 strain are needed.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microbiolres15020050/s1, Figure S1: GC–MS spectra of 5 important secondary metabolites present in ethyl acetate extract of the EIZ2 strain; Table S1: Resistance profile of multi-drug-resistant (MDR) clinical bacteria; Table S2: Molecular identification of the selected EIZ2 Actinobacteria isolate based on 16S rRNA gene sequencing.

Author Contributions

Conceived the experiments, S.R., F.Z.K. and B.B.; conducted the experiments, S.R. and F.Z.K.; validation, A.C., S.R. and B.B.; formal analysis, A.R., S.R. and M.E.A.; data curation, B.N., A.P., R.L. and S.R.; writing—original draft preparation, S.R.; writing—review and editing, S.R., F.Z.K., M.E.A., A.R., A.B., K.D., A.K., A.C., B.N., A.P., R.L. and B.B.; visualization, S.R.; supervision, A.C. and B.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request. The genomic sequence of Streptomyces sp. EIZ2 has been deposited at the National Centre for Biotechnology Information (NCBI) GenBank (https://www.ncbi.nlm.nih.gov/nucleotide/), accessed on 31 October 2023 under the accession number OR731196.

Conflicts of Interest

The authors declare no conflicts of interest. This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Courvalin, P. La Résistance des Bactéries aux Antibiotiques: Combinaisons de Mécanismes Biochimiques et Génétiques. Bull. Acad. Vet. Fr. 2008, 161, 7–12. [Google Scholar] [CrossRef]
  2. Barka, E.A.; Vatsa, P.; Sanchez, L.; Gaveau-Vaillant, N.; Jacquard, C.; Klenk, H.-P.; Clément, C.; Ouhdouch, Y.; van Wezel, G.P. Taxonomy, Physiology, and Natural Products of Actinobacteria. Microbiol. Mol. Biol. Rev. 2016, 80, 1–43. [Google Scholar] [CrossRef] [PubMed]
  3. Davies, J.E.; Davies, D.K. Origins and Evolution of Antibiotic Resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417–433. [Google Scholar] [CrossRef] [PubMed]
  4. Martínez, J.L.; Baquero, F.; Andersson, D.I. Predicting Antibiotic Resistance. Nat. Rev. Microbiol. 2007, 5, 958–965. [Google Scholar] [CrossRef] [PubMed]
  5. Levy, S.B.; Marshall, B. Antibacterial Resistance Worldwide: Causes, Challenges and Responses. Nat. Med. 2004, 10, S122–S129. [Google Scholar] [CrossRef] [PubMed]
  6. CDC. Antibiotic Resistance Threats in The United States 2019; CDC: Atlanta, GA, USA, 2019; Volume 10. [CrossRef]
  7. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; Government of the United Kingdom: London, UK, 2016.
  8. Checa, J.; Aran, J.M. Reactive Oxygen Species: Drivers of Physiological and Pathological Processes. J. Inflamm. Res. 2020, 13, 1057–1073. [Google Scholar] [CrossRef] [PubMed]
  9. Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 2017, 8416763. [Google Scholar] [CrossRef]
  10. Aldosari, S.; Awad, M.; Harrington, E.O.; Sellke, F.W.; Abid, M.R. Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology. Antioxidants 2018, 7, 14. [Google Scholar] [CrossRef] [PubMed]
  11. Li, H.; Zhou, X.; Huang, Y.; Liao, B.; Cheng, L.; Ren, B. Reactive Oxygen Species in Pathogen Clearance: The Killing Mechanisms, the Adaption Response, and the Side Effects. Front. Microbiol. 2021, 11, 622534. [Google Scholar] [CrossRef] [PubMed]
  12. Takahashi, N.; Gruber, C.C.; Yang, J.H.; Liu, X.; Braff, D.; Yashaswini, C.N. Lethality of MalE-LacZ Hybrid Protein Shares Mechanistic Attributes with Oxidative Component of Antibiotic Lethality. Proc. Natl. Acad. Sci. USA 2017, 114, 9164–9169. [Google Scholar] [CrossRef] [PubMed]
  13. Kohanski, M.A.; Depristo, M.A.; Collins, J.J. Article Sublethal Antibiotic Treatment Leads to Multidrug. Mol. Cell 2010, 37, 311–320. [Google Scholar] [CrossRef]
  14. Wang, Y.; Lu, J.; Engelstädter, J.; Zhang, S.; Bond, P.L.; Guo, J. Non-Antibiotic Pharmaceuticals Enhance the Transmission of Exogenous Antibiotic Resistance Genes through Bacterial Transformation. ISME J. 2020, 14, 2179–2196. [Google Scholar] [CrossRef] [PubMed]
  15. Bharadwaj, A.; Rastogi, A.; Pandey, S.; Gupta, S.; Sohal, J.S. Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis. Biomed Res. Int. 2022, 2022, 5419874. [Google Scholar] [CrossRef] [PubMed]
  16. Dancer, S.J. How Antibiotics Can Make Us Sick: The Less Obvious Adverse Effects of Antimicrobial Chemotherapy. Lancet Infect. Dis. 2004, 4, 611–619. [Google Scholar] [CrossRef] [PubMed]
  17. Boughachiche, F.; Reghioua, S.; Zerizer, H.; Boulahrouf, A. Activité Antibactérienne d’espèces Rares de Streptomyces Contre des Isolats Cliniques Multirésistants. Ann. Biol. Clin. 2012, 70, 169–174. [Google Scholar] [CrossRef] [PubMed]
  18. Ningthouja, D.S.; Sanasam, S.; Nimaichand, S. Screening of Actinomycete Isolates from Niche Habitats in Manipur for Antibiotic Activity. Am. J. Biochem. Biotechnol. 2009, 5, 221–225. [Google Scholar] [CrossRef]
  19. Rammali, S.; Hilali, L.; Dari, K.; Bencharki, B.; Rahim, A.; Timinouni, M.; Gaboune, F.; El Aalaoui, M.; Khattabi, A. Antimicrobial and Antioxidant Activities of Streptomyces Species from Soils of Three Different Cold Sites in the Fez-Meknes Region Morocco. Sci. Rep. 2022, 12, 17233. [Google Scholar] [CrossRef] [PubMed]
  20. De Lima Procópio, R.E.; da Silva, I.R.; Martins, M.K.; de Azevedo, J.L.; de Araújo, J.M. Antibiotics Produced by Streptomyces. Braz. J. Infect. Dis. 2012, 16, 466–471. [Google Scholar] [CrossRef] [PubMed]
  21. Chandra, P.; Sharma, R.K.; Arora, D.S. Antioxidant Compounds from Microbial Sources: A Review. Food Res. Int. 2020, 129, 108849. [Google Scholar] [CrossRef] [PubMed]
  22. Quinn, G.A.; Banat, A.M.; Abdelhameed, A.M.; Banat, I.M. Streptomyces from Traditional Medicine: Sources of New Innovations in Antibiotic Discovery. J. Med. Microbiol. 2020, 69, 1040. [Google Scholar] [CrossRef] [PubMed]
  23. Anandan, R.; Dharumadurai, D.; Manogaran, G.P. An Introduction to Actinobacteria. In Actinobacteria—Basics and Biotechnological Applications; IntechOpen: London, UK, 2016. [Google Scholar]
  24. Sengupta, S.; Pramanik, A.; Ghosh, A.; Bhattacharyya, M. Antimicrobial Activities of Actinomycetes Isolated from Unexplored Regions of Sundarbans Mangrove Ecosystem. BMC Microbiol. 2015, 15, 170. [Google Scholar] [CrossRef] [PubMed]
  25. Thirion-Merle, V. Spectrométrie de Fluorescence X. In Circulation et Provenance Des Matériaux Dans Les Sociétés Anciennes; Dillmann, P., Bellot-Gurlet, L., Eds.; Editions des archives contemporaines, Coll; Sciences archéologiques: Lyon, France, 2014; pp. 291–298. ISBN 978-2-8130-0163-4. [Google Scholar] [CrossRef]
  26. Li, Q.; Chen, X.; Jiang, Y.; Jiang, C. Morphological Identification of Actinobacteria. In Actinobacteria—Basics and Biotechnological Applications; IntechOpen: London, UK, 2016; pp. 59–86. [Google Scholar]
  27. Arasu, M.V.; Duraipandiyan, V.; Agastian, P.; Ignacimuthu, S. In Vitro Antimicrobial Activity of Streptomyces spp. ERI-3 Isolated from Western Ghats Rock Soil (India). J. Mycol. Med. 2009, 19, 22–28. [Google Scholar] [CrossRef]
  28. Lee, E.J.; Hwang, K.Y.; Lee, H.-S.; Chung, N. Characterization of a New Streptomyces Sp. A1022 as a Potential Biocontrol Agent. J. Korean Soc. Appl. Biol. Chem. 2011, 54, 488–493. [Google Scholar] [CrossRef]
  29. Bouaziz, S.; Messis, A.; Bettache, A.; El Hadj, M.D.O.; Benallaoua, E.S. Antifungal Activity of Streptomyces sp. 14 Strain Isolated from Ouargla (Southeast of Algeria): Identification, Production and Characterization of the Active Substance. Int. J. Biosci. 2016, 9, 45–56. [Google Scholar]
  30. Thakur, D.; Yadav, A.; Gogoi, B.K.; Bora, T.C. Isolation and Screening of Streptomyces in Soil of Protected Forest Areas from the States of Assam and Tripura, India, for Antimicrobial Metabolites. J. Mycol. Med. 2007, 17, 242–249. [Google Scholar] [CrossRef]
  31. Das, R.; Romi, W.; Das, R.; Sharma, H.K.; Thakur, D. Antimicrobial Potentiality of Actinobacteria Isolated from Two Microbiologically Unexplored Forest Ecosystems of Northeast India. BMC Microbiol. 2018, 18, 71. [Google Scholar] [CrossRef] [PubMed]
  32. Marimuthu, S.; Karthic, C.; Mostafa, A.A.; Al-Enazi, N.M.; Abdel-Raouf, N.; Sholkamy, E.N. Antifungal Activity of Streptomyces sp. SLR03 against Tea Fungal Plant Pathogen Pestalotiopsis Theae. J. King Saud Univ. 2020, 32, 3258–3264. [Google Scholar] [CrossRef]
  33. Weisburg, W.G.; Barns, S.M.; Pelletier, D.A.; Lane, D.J. 16S Ribosomal DNA Amplification for Phylogenetic Study. J. Bacteriol. 1991, 173, 697–703. [Google Scholar] [CrossRef] [PubMed]
  34. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef] [PubMed]
  35. Badji, B.; Riba, A.; Mathieu, F.; Lebrihi, A.; Sabaou, N. Activité Antifongique d’une Souche d’Actinomadurad ’origine Saharienne sur Divers Champignons Pathogènes et Toxinogènes. J. Mycol. Med. 2005, 15, 211–219. [Google Scholar] [CrossRef]
  36. Boughachiche, F.; Reghioua, S.; Zerizer, H.; Oulmi, L.; Boudemagh, A.; Kitouni, M.; Boulahrouf, A. Production et Caractérisation Préliminaire des Antibiotiques Isolés d’une Actinomycetale Isolée de Sebkha de Ain Mlila (Algérie). Antibiotiques 2005, 7, 234–238. [Google Scholar] [CrossRef]
  37. Pare, A.; Mandhyan, B.L. Food Process Engineering and Technology; New India Publishing Agency: New Delhi, India, 2011. [Google Scholar]
  38. Zitouni, A.; Boudjella, H.; Lamari, L.; Badji, B.; Mathieu, F.; Lebrihi, A.; Sabaou, N. Nocardiopsis and Saccharothrix Genera in Saharan Soils in Algeria: Isolation, Biological Activities and Partial Characterization of Antibiotics. Res. Microbiol. 2005, 156, 984–993. [Google Scholar] [CrossRef] [PubMed]
  39. Aouiche, A.; Sabaou, N.; Meklat, A.; Zitouni, A.; Mathieu, F.; Lebrihi, A. Activité Antimicrobienne de Streptomyces sp. PAL111 d’origine Saharienne Contre Divers Microorganismes Cliniques et Toxinogènes Résistants Aux Antibiotiques. J. Mycol. Med. 2012, 22, 42–51. [Google Scholar] [CrossRef] [PubMed]
  40. Crawford, D.L.; Lynch, J.M.; Whipps, J.M.; Ousley, M.A. Isolation and Characterization of Actinomycete Antagonists of a Fungal Root Pathogen. Appl. Environ. Microbiol. 1993, 59, 3899–3905. [Google Scholar] [CrossRef] [PubMed]
  41. Tresner, H.D.; Hayes, J.A.; Backus, E.J. Differential Tolerance of Streptomycetes to Sodium Chloride as a Taxonomic Aid. Appl. Microbiol. 1968, 16, 1134–1136. [Google Scholar] [CrossRef] [PubMed]
  42. Kumazawa, S.; Taniguchi, M.; Suzuki, Y.; Shimura, M.; Kwon, M.-S.; Nakayama, T. Antioxidant Activity of Polyphenols in Carob Pods. J. Agric. Food Chem. 2002, 50, 373–377. [Google Scholar] [CrossRef] [PubMed]
  43. Bahorun, T.; Gressier, B.; Trotin, F.; Brunet, C.; Dine, T.; Luyckx, M.; Vasseur, J.; Cazin, M.; Cazin, J.C.; Pinkas, M. Oxygen Species Scavenging Activity of Phenolic Extracts from Hawthorn Fresh Plant Organs and Pharmaceutical Preparations. Arzneimittelforschung 1996, 46, 1086–1089. [Google Scholar] [PubMed]
  44. Blois, M.S. Comparison of Different Organic Solvents on Antioxidant Activity of Astaxanthin Extracted from Hematococcus pluvialis. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  45. Re, R.; Nicoletta, P.; Anna, P.; Ananth, P.; Min, Y.; Catherine, R.-E. Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef] [PubMed]
  46. Oyaizu, M. Antioxidative Activities of Browning Reaction Prepared from Glucosamine. Jpn. J. Nutr. 1986, 44, 307–315. [Google Scholar] [CrossRef]
  47. Chakraborty, B.; Kumar, R.S.; Almansour, A.I.; Perumal, K.; Nayaka, S.; Brindhadevi, K. Streptomyces filamentosus Strain KS17 Isolated from Microbiologically Unexplored Marine Ecosystems Exhibited a Broad Spectrum of Antimicrobial Activity against Human Pathogens. Process Biochem. 2022, 117, 42–52. [Google Scholar] [CrossRef]
  48. Rajendran, K.; Sen, S.; Suja, G.; Senthil, S.L.; Kumar, T.V. Evaluation of Cytotoxicity of Hematite Nanoparticles in Bacteria and Human Cell Lines. Colloids Surf. B Biointerfaces 2017, 157, 101–109. [Google Scholar] [CrossRef] [PubMed]
  49. Zhu, Q.Y.; Holt, R.R.; Lazarus, S.A.; Orozco, T.J.; Keen, C.L. Inhibitory Effects of Cocoa Flavanols and Procyanidin Oligomers on Free Radical-Induced Erythrocyte Hemolysis. Exp. Biol. Med. 2002, 227, 321–329. [Google Scholar] [CrossRef]
  50. Al-Mulla, A. A Review: Biological Importance of Heterocyclic Compounds. Pharma Chem. 2017, 9, 141–147. [Google Scholar]
  51. Baregama, L.K.; Ahmed, M.; Dak, G.; Sharma, K.; Talesara, G.L. Evaluation of the Antimicrobial Activity of Some Novel Alpha Substituted Hydroxylamine Derivatives. Indian J. Pharmacol. 2004, 36, 315. [Google Scholar]
  52. In, Y.-W.; Kim, J.-J.; Kim, H.-J.; Oh, S.-W. Antimicrobial Activities of Acetic Acid, Citric Acid and Lactic Acid against Shigella Species. J. Food Saf. 2013, 33, 79–85. [Google Scholar] [CrossRef]
  53. Devendran, G.; Sivamani, G. Phytochemical Analysis of Leaf Extract of Plant Costus spicatus By GCMS Method. J. Drug Deliv. Ther. 2015, 5, 24–26. [Google Scholar] [CrossRef]
  54. Sin, S.; Myint, K. Study on Traditional Medicine (Setkupala No. 2) for Eye Diseases. J. Myanmar Acad. Arts Sci. 2020, XVIII, 181–189. [Google Scholar]
  55. Itoh, T.; Muramatsu, M.; Miyazono, D.; Koketsu, M.; Fujita, S.; Hashizume, T. Phenolic Glycosides Citrulluside H and Citrulluside T Isolated from Young Watermelon (Citrullus Lanatus) Fruit Have Beneficial Effects against Cutibacterium Acnes-Induced Skin Inflammation. Nat. Prod. Commun. 2023, 18, 1934578X221143202. [Google Scholar] [CrossRef]
  56. Nahar, L.; Russell, W.R.; Middleton, M.; Shoeb, M.; Sarker, S.D. Antioxidant Phenylacetic Acid Derivatives from the Seeds of Ilex aquifolium. Acta Pharm. 2005, 55, 187–193. [Google Scholar] [PubMed]
  57. Kim, Y.; Cho, J.Y.; Kuk, J.H.; Moon, J.H.; Cho, J.I.; Kim, Y.C.; Park, K.H. Identification and Antimicrobial Activity of Phenylacetic Acid Produced by Bacillus licheniformis Isolated from Fermented Soybean, Chungkook-Jang. Curr. Microbiol. 2004, 48, 312–317. [Google Scholar] [CrossRef] [PubMed]
  58. Hwang, B.K.; Lim, S.W.; Kim, B.S.; Lee, J.Y.; Moon, S.S. Isolation and in Vivo and in Vitro Antifungal Activity of Phenylacetic Acid and Sodium Phenylacetate from Streptomyces humidus. Appl. Environ. Microbiol. 2001, 67, 3739–3745. [Google Scholar] [CrossRef] [PubMed]
  59. Mangamuri, U.; Muvva, V.; Poda, S.; Naragani, K.; Munaganti, R.K.; Chitturi, B.; Yenamandra, V. Bioactive Metabolites Produced by Streptomyces Cheonanensis VUK-A from Coringa Mangrove Sediments: Isolation, Structure Elucidation and Bioactivity. 3 Biotech 2016, 6, 63. [Google Scholar] [CrossRef] [PubMed]
  60. Davet, P. Vie Microbienne du Sol et Production Végétale; Editions Quae: Versailles, France, 1996. [Google Scholar]
  61. Yang, C.; Wang, X.; Miao, F.; Zhenyi, L.; Tang, W.; Sun, J. Assessing the Effect of Soil Salinization on Soil Microbial Respiration and Diversities under Incubation Conditions. Appl. Soil Ecol. 2020, 155, 103671. [Google Scholar] [CrossRef]
  62. Wichern, J.; Wichern, F.; Joergensen, R.G. Impact of Salinity on Soil Microbial Communities and the Decomposition of Maize in Acidic Soils. Geoderma 2006, 137, 100–108. [Google Scholar] [CrossRef]
  63. Lee, J.Y.; Hwang, B.K. Diversity of Antifungal Actinomycetes in Various Vegetative Soils of Korea. Can. J. Microbiol. 2002, 48, 407–417. [Google Scholar] [CrossRef]
  64. Maldonado, L.A.; Stach, J.E.M.; Pathom-Aree, W.; Ward, A.C.; Bull, A.T.; Goodfellow, M. Diversity of Cultivable Actinobacteria in Geographically Widespread Marine Sediments. Antonie Van Leeuwenhoek Int. J. Gen. Mol. Microbiol. 2005, 87, 11–18. [Google Scholar] [CrossRef] [PubMed]
  65. Del Giorgio, P.A.; Bouvier, T.C. Linking the Physiologic and Phylogenetic Successions in Free-Living Bacterial Communities along an Estuarine Salinity Gradient. Limnol. Oceanogr. 2002, 47, 471–486. [Google Scholar] [CrossRef]
  66. Ramos, I.; Guzmán, S.; Escalante, L.; Imriskova, I.; Rodríguez-Sanoja, R.; Sanchez, S.; Langley, E. Glucose Kinase Alone Cannot Be Responsible for Carbon Source Regulation in Streptomyces peucetius var. Caesius. Res. Microbiol. 2004, 155, 267–274. [Google Scholar] [CrossRef]
  67. Martín, J.F.; Liras, P.; Sánchez, S. Modulation of Gene Expression in Actinobacteria by Translational Modification of Transcriptional Factors and Secondary Metabolite Biosynthetic Enzymes. Front. Microbiol. 2021, 12, 630–694. [Google Scholar] [CrossRef]
  68. Burns, K.E.; Darwin, K.H. Pupylation versus Ubiquitylation: Tagging for Proteasome-Dependent Degradation. Cell. Microbiol. 2010, 12, 424–431. [Google Scholar] [CrossRef] [PubMed]
  69. Ryu, Y.-G.; Butler, M.J.; Chater, K.F.; Lee, K.J. Engineering of Primary Carbohydrate Metabolism for Increased Production of Actinorhodin in Streptomyces coelicolor. Appl. Environ. Microbiol. 2006, 72, 7132–7139. [Google Scholar] [CrossRef]
  70. Lewin, G.R.; Carlos, C.; Chevrette, M.G.; Horn, H.A.; McDonald, B.R.; Stankey, R.J.; Fox, B.G.; Currie, C.R. Evolution and Ecology of Actinobacteria and Their Bioenergy Applications. Annu. Rev. Microbiol. 2016, 70, 235–254. [Google Scholar] [CrossRef] [PubMed]
  71. Jiang, C.; Xu, L. Actinomycete Diversity in Unusual Habitats. Actinomycetes 1993, 4, 47–57. [Google Scholar]
  72. Singh, A.P.; Singh, R.B.; Mishra, S. Microbial and Biochemical Aspects of Antibiotic Producing Microorganisms from Soil Samples of Certain Industrial Area of India—An Overview. Open Nutraceuticals J. 2012, 5, 107–112. [Google Scholar] [CrossRef]
  73. Choi, K.-Y. Bioprocess of Microbial Melanin Production and Isolation. Front. Bioeng. Biotechnol. 2021, 9, 765110. [Google Scholar] [CrossRef]
  74. Dastager, S.G.; Li, W.J.; Dayanand, A.; Tang, S.K.; Tian, X.P.; Zhi, X.Y.; Xu, L.H.; Jiang, C.L. Seperation, Identification and Analysis of Pigment (Melanin) Production in Streptomyces. Afr. J. Biotechnol. 2006, 5, 1131–1134. [Google Scholar]
  75. Pavan, M.E.; López, N.I.; Pettinari, M.J. Melanin Biosynthesis in Bacteria, Regulation and Production Perspectives. Appl. Microbiol. Biotechnol. 2020, 104, 1357–1370. [Google Scholar] [CrossRef] [PubMed]
  76. Wang, L.; Li, Y.; Li, Y. Metal Ions Driven Production, Characterization and Bioactivity of Extracellular Melanin from Streptomyces sp. ZL-24. Int. J. Biol. Macromol. 2019, 123, 521–530. [Google Scholar] [CrossRef] [PubMed]
  77. Wibowo, J.T.; Kellermann, M.Y.; Petersen, L.E.; Alfiansah, Y.R.; Lattyak, C.; Schupp, P.J. Characterization of an Insoluble and Soluble Form of Melanin Produced by Streptomyces cavourensis SV 21, a Sea Cucumber Associated Bacterium. Mar. Drugs 2022, 20, 54. [Google Scholar] [CrossRef] [PubMed]
  78. Robinson, T.; Singh, D.; Nigam, P. Solid-State Fermentation: A Promising Microbial Technology for Secondary Metabolite Production. Appl. Microbiol. Biotechnol. 2001, 55, 284–289. [Google Scholar] [CrossRef] [PubMed]
  79. Bigelis, R.; He, H.; Yang, H.Y.; Chang, L.P.; Greenstein, M. Production of Fungal Antibiotics Using Polymeric Solid Supports in Solid-State and Liquid Fermentation. J. Ind. Microbiol. Biotechnol. 2006, 33, 815–826. [Google Scholar] [CrossRef] [PubMed]
  80. Pattanaik, B.N.; Mandalia, H.C. Ethyl Acetate: Properties, Production Processes and Applications—A Review. Int. J. Curr. Res. Rev. 2011, 3, 23–40. [Google Scholar]
  81. Balasundram, N.; Sundram, K.; Samman, S. Phenolic Compounds in Plants and Agri-Industrial by-Products: Antioxidant Activity, Occurrence, and Potential Uses. Food Chem. 2006, 99, 191–203. [Google Scholar] [CrossRef]
  82. Manach, C.; Mazur, A.; Scalbert, A. Polyphenols and Prevention of Cardiovascular Diseases. Curr. Opin. Lipidol. 2005, 16, 77–84. [Google Scholar] [CrossRef] [PubMed]
  83. Kofujita, H.; Yaguchi, M.; Doi, N.; Suzuki, K. A Novel Cytotoxic Prenylated Flavonoid from the Root of Morus Alba. J. Insect Biotechnol. Sericol. 2004, 73, 113–116. [Google Scholar]
  84. Tan, L.T.H.; Chan, K.G.; Khan, T.M.; Bukhari, S.I.; Saokaew, S.; Duangjai, A.; Pusparajah, P.; Lee, L.H.; Goh, B.H. Streptomyces sp. MUM212 as a Source of Antioxidants with Radical Scavenging and Metal Chelating Properties. Front. Pharmacol. 2017, 8, 276. [Google Scholar] [CrossRef] [PubMed]
  85. Yogeswari, S.; Ramalakshmi, S.; Neelavathy, R.; Muthumary, J. Identification and Comparative Studies of Different Volatile Fractions from Monochaetia kansensis by GCMS. Glob. J. Pharmacol. 2012, 6, 65–71. [Google Scholar]
  86. Bahorun, T.; Soobrattee, M.A.; Luximon-ramma, M.V.; Aruoma, P.O.I. Free Radicals and Antioxidants in Cardiovascular Health and Disease. Internet J. Med. Update—EJOURNAL 2006, 1, 25–41. [Google Scholar] [CrossRef]
  87. Droge, W. Free Radicals in the Physiological Control of Cell Function. Physiol. Rev. 2002, 82, 47–95. [Google Scholar] [CrossRef] [PubMed]
  88. Kunwar, A.; Priyadarsini, K. Free Radicals, Oxidative Stress and Importance of Antioxidants in Human Health. J. Med. Allied Sci. 2011, 1, 53–60. [Google Scholar]
  89. Yilma, S.; Cannon-Sykora, J.; Samoylov, A.; Lo, T.; Liu, N.; Brinker, C.J.; Neely, W.C.; Vodyanoy, V. Large-Conductance Cholesterol—Amphotericin B Channels in Reconstituted Lipid Bilayers. Biosens. Bioelectron. 2007, 22, 1359–1367. [Google Scholar] [CrossRef] [PubMed]
  90. Boeckler, G.A.; Gershenzon, J.; Unsicker, S.B. Phenolic Glycosides of the Salicaceae and Their Role as Anti-Herbivore Defenses. Phytochemistry 2011, 72, 1497–1509. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Evaluation of the antimicrobial activity of pure isolates of Actinobacteria using the double layer method in ISP2 medium. (A) Antimicrobial activity of EIZ2 isolate against Candida albicans ATCC 60,193; (B) antimicrobial activity of EIZ3 and EIZ14 isolates against Staphylococcus aureus ATCC 25,923; (C) antimicrobial activity of EIZ2 and EIZ5 isolates against Candida albicans ATCC 60,193; (D) antimicrobial activity of EIZ19 and EIZ29 isolates against Staphylococcus aureus ATCC 25,923; (E) antimicrobial activity of EIZ1 isolate against Escherichia coli ATCC 25,922; (F) antimicrobial activity of EIZ2 isolate against Staphylococcus aureus ATCC 25,923.
Figure 1. Evaluation of the antimicrobial activity of pure isolates of Actinobacteria using the double layer method in ISP2 medium. (A) Antimicrobial activity of EIZ2 isolate against Candida albicans ATCC 60,193; (B) antimicrobial activity of EIZ3 and EIZ14 isolates against Staphylococcus aureus ATCC 25,923; (C) antimicrobial activity of EIZ2 and EIZ5 isolates against Candida albicans ATCC 60,193; (D) antimicrobial activity of EIZ19 and EIZ29 isolates against Staphylococcus aureus ATCC 25,923; (E) antimicrobial activity of EIZ1 isolate against Escherichia coli ATCC 25,922; (F) antimicrobial activity of EIZ2 isolate against Staphylococcus aureus ATCC 25,923.
Microbiolres 15 00050 g001
Figure 2. Evaluation of antimicrobial activity in the ethyl acetate extract from isolate EIZ2 using the disc diffusion method on MH medium. (A) Antimicrobial activity of EIZ2 isolate against clinical Klebsiella pneumonie 19K 929; (B) Antimicrobial activity of EIZ2 isolate against clinical Klebsiella pneumoniae 20B1572; (C) Antimicrobial activity of EIZ2 isolate against clinical Proteus sp. 19K1313; (C+) positive control (nalidixic acid); (C−) negative control (DMSO); (Dich) dichloromethane; (EA) ethyl acetate; (PR) residual phase.
Figure 2. Evaluation of antimicrobial activity in the ethyl acetate extract from isolate EIZ2 using the disc diffusion method on MH medium. (A) Antimicrobial activity of EIZ2 isolate against clinical Klebsiella pneumonie 19K 929; (B) Antimicrobial activity of EIZ2 isolate against clinical Klebsiella pneumoniae 20B1572; (C) Antimicrobial activity of EIZ2 isolate against clinical Proteus sp. 19K1313; (C+) positive control (nalidixic acid); (C−) negative control (DMSO); (Dich) dichloromethane; (EA) ethyl acetate; (PR) residual phase.
Microbiolres 15 00050 g002
Figure 3. Morphological (A,C) and microscopic (B,D) characteristics of 2 active Actinobacteria isolates. (A,B) EIZ1 isolate; (C,D) EIZ2 isolate.
Figure 3. Morphological (A,C) and microscopic (B,D) characteristics of 2 active Actinobacteria isolates. (A,B) EIZ1 isolate; (C,D) EIZ2 isolate.
Microbiolres 15 00050 g003
Figure 4. Phylogenetic tree constructed via the maximum likelihood tree test using the 16S rRNA gene, illustrating the evolutionary relationships between Streptomyces sp. EIZ2 (highlighted with a red triangle) and closely related taxa. The bar (0.02) denotes substitutions per nucleotide position (1% sequence divergence). GenBank accession numbers are indicated in brackets. Cryptobacterium curtum was the outgroup in the analysis. T: Type strain.
Figure 4. Phylogenetic tree constructed via the maximum likelihood tree test using the 16S rRNA gene, illustrating the evolutionary relationships between Streptomyces sp. EIZ2 (highlighted with a red triangle) and closely related taxa. The bar (0.02) denotes substitutions per nucleotide position (1% sequence divergence). GenBank accession numbers are indicated in brackets. Cryptobacterium curtum was the outgroup in the analysis. T: Type strain.
Microbiolres 15 00050 g004
Figure 5. Pearson correlation analysis graphics. (A) Pearson correlation between DPPH and total phenolic content, (B) Pearson correlation between DPPH and flavonoids content, (C) Pearson correlation between ABTS and total phenolic content, (D) Pearson correlation between ABTS and flavonoids content, (E) Pearson correlation between FRAP and total phenolic content, and (F) Pearson correlation between FRAP and flavonoids content. **** (p  <  0.0001) means highly significant between tests.
Figure 5. Pearson correlation analysis graphics. (A) Pearson correlation between DPPH and total phenolic content, (B) Pearson correlation between DPPH and flavonoids content, (C) Pearson correlation between ABTS and total phenolic content, (D) Pearson correlation between ABTS and flavonoids content, (E) Pearson correlation between FRAP and total phenolic content, and (F) Pearson correlation between FRAP and flavonoids content. **** (p  <  0.0001) means highly significant between tests.
Microbiolres 15 00050 g005
Figure 6. UV-visible spectrum of the ethyl acetate-active crude extract of EIZ2 isolate.
Figure 6. UV-visible spectrum of the ethyl acetate-active crude extract of EIZ2 isolate.
Microbiolres 15 00050 g006
Figure 7. Evaluation of the toxicity of ethyl acetate extract of EIZ2 isolate using the hemolysis test on human red blood cells. SDS: positive control; PBS (NC): negative control.
Figure 7. Evaluation of the toxicity of ethyl acetate extract of EIZ2 isolate using the hemolysis test on human red blood cells. SDS: positive control; PBS (NC): negative control.
Microbiolres 15 00050 g007
Figure 8. GC–MS of ethyl acetate crude extract of EIZ2, with peaks indicating the presence of bioactive compounds (according to the NIST database).
Figure 8. GC–MS of ethyl acetate crude extract of EIZ2, with peaks indicating the presence of bioactive compounds (according to the NIST database).
Microbiolres 15 00050 g008
Table 1. Physico-chemical analysis of soil samples.
Table 1. Physico-chemical analysis of soil samples.
Physico-Chemical ParametersSite ASite B
Textural soil typesSilty claySandy
Clay (%)339
Sand (%)2875
Silt (%)3914
pH8.087.79
Electrical conductivity (ds/m)0.0040.003
Mg (%)0.4480.327
Al (%)5.0884.653
Si (%)16.76921.229
P (%)0.2650.360
S (%)0.0680.138
Cl (%)0.0130.038
K (%)3.2332.103
Ca (%)1.2200.901
Mn (%)0.0870.039
Fe (%)6.5013.129
Cu (%)0.0080.004
Zn (%)0.0210.006
Ga (%)0.0040.002
Rb (%)0.0280.013
Sr (%)0.0180.007
Zr (%)0.0450.063
Ag (%)0.0950.084
Site A (garden soil); Site B (agriculture soil); EC: electrical conductivity.
Table 2. Total number of Actinobacteria colonies at Sites A and B using four different culture media.
Table 2. Total number of Actinobacteria colonies at Sites A and B using four different culture media.
Sampling Site for Soil SamplesThe Count of Actinobacteria Colonies across Various Isolation Media (Expressed as × 102 CFU/mL)The Total Number of Actinobacteria (Expressed × 102 CFU/mL)Count of Colonies with Specific Morphological Characteristics in Each MediumTotal Number
of Isolates
GAGLMM2Bennett GAGLMM2Bennett
Site A0320153804151029
Site B041912340312621
Total0739277207271650
Site A (garden soil); Site B (agriculture soil).
Table 3. Evaluation of the antimicrobial activity of Actinobacteria isolated by the double-layer method in ISP2 medium.
Table 3. Evaluation of the antimicrobial activity of Actinobacteria isolated by the double-layer method in ISP2 medium.
Actinobacteria IsolatesAntimicrobial Activity (mm)
Pseudomonas aeruginosa
ATCC 27,853
Staphylococcus aureus
ATCC 25,923
Escherichia coli
ATCC 25,922
Candida albicans
ATCC 60,193
EIZ1302031-
EIZ23240-41
EIZ3-5730-
EIZ4----
EIZ5----
EIZ6----
EIZ7----
EIZ8----
EIZ9-3020-
EIZ10----
EIZ11----
EIZ12----
EIZ13----
EIZ14--30-
EIZ15---24
EIZ16----
EIZ1720202025
EIZ18----
EIZ19454020-
EIZ20----
EIZ21----
EIZ22----
EIZ23----
EIZ24----
EIZ25----
EIZ26----
EIZ27----
EIZ28----
EIZ29154015-
EIZ30----
EIZ31----
EIZ32----
EIZ33----
EIZ34----
EIZ35----
EIZ36----
EIZ37-- 28
EIZ38-40--
EIZ39-23--
EIZ40-40--
EIZ41-25--
EIZ4220302018
EIZ43----
EIZ44----
EIZ454513-20
EIZ46----
EIZ47----
EIZ48----
EIZ49----
EIZ50----
(-) No inhibition zones.
Table 4. Secondary screening (antimicrobial activity of isolate EIZ2) was performed using the disc diffusion method, varying extraction solvents.
Table 4. Secondary screening (antimicrobial activity of isolate EIZ2) was performed using the disc diffusion method, varying extraction solvents.
Multi-Drug-Resistant Bacteria (MDR)PC BCNC DDM BAEA ARP D
Clinical Proteus sp. 19K1313--19.67 ± 1.5320 ± 1.00-
Clinical Proteus vulgaris 16C173725.5  ±  0.71-20 ± 1.0015 ± 1.00-
Clinical Klebsiella pneumonie 19K 929--16 ± 0.5822.66 ± 1.53-
Clinical Listeria monocytogenes25 ± 0.71--30 ± 2.08-
Clinical Escherichia coli 19L2418---15.67 ± 1.15-
Clinical Klebsiella pneumoniae 20B1572---40.67 ± 0.58-
Candida albicans ATCC 60,19327  ±  2.83--40.33 ± 0.57-
Values are the means ± SD (n = 2). Columns with different letters A, B, C, and D are significantly different (ordinary one-way ANOVA; Tukey’s multiple comparisons test; p Tukey’s multiple comparisons test, p < 0.05). (-) No zone of inhibition; (PC) positive control (nalidixic acid and cycloheximide); (NC) negative control (DMSO); (DM) dichloromethane; (EA) ethyl acetate; (PR) residual phase and disc diameter = 6 mm.
Table 5. Cultural, physiological, and biochemical characteristics of Actinobacteria isolates.
Table 5. Cultural, physiological, and biochemical characteristics of Actinobacteria isolates.
Test EIZ1EIZ2
Carbon assimilation
Amidon-2+
Mannitol+3+
Cellobiose3+3+
Sucrose++
Xylose+2+
Mannose3+3+
Fructose3+3+
Positive control (Glucose) 3+3+
pH tolerance
4.02-+
5.023+3+
6.453+3+
7.283+3+
8.023+3+
9.063+3+
10.022+2+
NaCl tolerance
1%3+3+
2%3+3+
3%3+3+
4%3+2+
5%3+2+
7%2+2+
10%-+
Temperature growth
4 °C3+3+
28 °C3+3+
37 °C3+3+
45 °C-2+
Growth on different ISP media
ISP13+3+
ISP23+3+
ISP72+2+
GYEA3+3+
Bennett2+3+
(-) No growth; (+) low growth; (2+) intermediate growth; (3+) good growth.
Table 6. Total phenolic and flavonoid contents of ethyl acetate extract of EIZ2 isolate.
Table 6. Total phenolic and flavonoid contents of ethyl acetate extract of EIZ2 isolate.
Concentration of EIZ2 Ethyl Acetate Extract (mg/mL)Total Phenolic Contents (mg GAE/mg Extract)Total Flavonoids Contents (mg QE/mg Extract)
0.20.261 ± 0.003ND
0.30.309 ± 0.010ND
0.40.361 ± 0.0050.006 ± 0.005
0.50.395 ± 0.0020.024 ± 0.003
0.60.430 ± 0.0040.053 ± 0.006
0.70.464 ± 0.0020.080 ± 0.006
0.80.470 ± 0.0130.114 ± 0.007
0.90.492 ± 0.0190.156 ± 0.005
10.546 ± 0.0130.1929 ± 0.02
Values expressed are the means  ±  SD (n  =  3). GAE: Gallic acid equivalent; QE: quercetin equivalent; ND: not detected.
Table 7. Antioxidant activities of ethyl acetate extract of EIZ2 isolate assessed using different antioxidant assays (DPPH, ABTS, and FRAP).
Table 7. Antioxidant activities of ethyl acetate extract of EIZ2 isolate assessed using different antioxidant assays (DPPH, ABTS, and FRAP).
Concentrations
(mg/mL)
Antioxidant Activities
EIZ2 Ethyl Acetate ExtractTrolox (PC)Ascorbic Acid (PC)
DPPH Free Radical Scavenging Activity (%)ABTS Free Radical Scavenging Activity (%)FRAP (mg AAE/mg Extract)ABTS Free Radical Scavenging Activity (%)DPPH Free Radical Scavenging Activity (%)
0.22.91 ± 0.92 ****ND0.43 ± 0.0127.54 ± 0.9433.13 ± 1.12
0.37.10 ± 0.83 ****1.32 ± 1.96 ****0.49 ± 0.0133.09 ± 1.1839.09 ± 0.70
0.411.12 ± 0.86 ****2.56 ± 0.42 ****0.55 ± 0.0137.64 ± 0.8642.14 ± 0.61
0.518.19 ± 0.26 ****6.92 ± 0.35 ****0.61 ± 0.0141.06 ± 0.7146.86 ± 0.58
0.622.04 ± 0.35 ****10.47 ± 0.80 ****0.66 ± 0.0145.85 ± 1.2951.55 ± 1.31
0.725.92 ± 0.26 ****15.41 ± 1.00 ****0.72 ± 0.0149.78 ± 0.5656.28 ± 0.53
0.830.45 ± 0.46 ****19.67 ± 2.91 ****0.76 ± 0.0154.19 ± 0.6559.49 ± 0.75
0.934.63 ± 0.90 ****25.69 ± 0.99 ****0.81 ± 0.0158.22 ± 0.7162.24 ± 0.76
137.78 ± 1.93 ****30.58 ± 1.78 ****0.89 ± 0.0263.44 ± 0.8565.32 ± 1.01
Values expressed are the means ± SD (n = 3). Symbol (****) indicates a p < 0.0001 significant difference between ethyl acetate extract. EIZ2 and controls according to a one-way analysis of variance (ANOVA) using Tukey’s multiple comparisons test. ND: Not detected; AAE: ascorbic acid equivalent; PC: positive control.
Table 8. Compounds identified by GC–MS from ethyl acetate crude extract of EIZ2 strain.
Table 8. Compounds identified by GC–MS from ethyl acetate crude extract of EIZ2 strain.
RT (Time)Area (%)M.W.
(g/mol)
Molecular
Formula
Compound
Name
NIST Database Similarity (%)Reported Bioactivities
1.6691.08124.18C7H12N22,3-Diazabicyclo [2.2.1] hept-2-ene,1,4-dimethyl-43Antifungal activity, anti-inflammation, anti-bacterial, antioxidants, anticonvulsant, antiallergic, herbicidal activity, and anticancer [50]
1.7250.52103.16C5H13NO Hydroxylamine, O-pentyl-9Antimicrobial activity [51]
2.79537.3060.05C2H4O2Acetic acid91Antimicrobial activity [52]
2.9311.81104.10C4H8O31,2-Ethanediol, monoacetate45Antioxidant activities [53]
4.4184.15106.12C4H10O3Ethanol, 2,2’-oxybis-40Antimicrobial and antioxidant [54]
5.8833.53118.13C5H10O3Butanoic acid, 3-hydroxy-3-methyl-72Anti-inflammatory, antioxidant [55]
13.78222.94136.14C8H8O2Benzeneacetic acid94Antifungal, Antimicrobial, and Antioxidant [56,57,58]
21.9639.69222.24C12H14O4Diethyl phthalate97Antimicrobial, Antifungal [59]
RT: Retention time; M.W.: molecular weight; NIST: National Institute of Standards and Technology
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rammali, S.; Kamal, F.Z.; El Aalaoui, M.; Rahim, A.; Baidani, A.; Dari, K.; Khattabi, A.; Ciobică, A.; Novac, B.; Petroaie, A.; et al. Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil. Microbiol. Res. 2024, 15, 762-786. https://doi.org/10.3390/microbiolres15020050

AMA Style

Rammali S, Kamal FZ, El Aalaoui M, Rahim A, Baidani A, Dari K, Khattabi A, Ciobică A, Novac B, Petroaie A, et al. Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil. Microbiology Research. 2024; 15(2):762-786. https://doi.org/10.3390/microbiolres15020050

Chicago/Turabian Style

Rammali, Said, Fatima Zahra Kamal, Mohamed El Aalaoui, Abdellatif Rahim, Aziz Baidani, Khadija Dari, Abdelkrim Khattabi, Alin Ciobică, Bogdan Novac, Antoneta Petroaie, and et al. 2024. "Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil" Microbiology Research 15, no. 2: 762-786. https://doi.org/10.3390/microbiolres15020050

APA Style

Rammali, S., Kamal, F. Z., El Aalaoui, M., Rahim, A., Baidani, A., Dari, K., Khattabi, A., Ciobică, A., Novac, B., Petroaie, A., Lefter, R., & Bencharki, B. (2024). Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil. Microbiology Research, 15(2), 762-786. https://doi.org/10.3390/microbiolres15020050

Article Metrics

Back to TopTop